Advisers to the U.S. Food and Drug Administration are due to meet in June to decide on whether to recommend authorizing Moderna Inc’s vaccine for children below 6 years old, and Pfizer Inc and BioNTech SE’s COVID-19 vaccine for children below 5 years old. Here is a look at…

Read Full Article (External Site)